Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy

Clinical trial NCT01718158 · COMPLETED

Trial details

NCT number

NCT01718158

Sponsor

Bristol-Myers Squibb

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2013-01-01

Primary completion

2014-10-01

Enrollment

444

View on ClinicalTrials.gov